| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240332B1 Streptococcus pyogenes virulence genes and proteins and their use |
| 01/23/2008 | EP1237880B1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1188057B1 Incorporation and applications of biomolecular interactions within a carrier |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111523A Process for producing natural immunobiotic extract and uses thereof |
| 01/23/2008 | CN101111518A Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111517A Novel peptides which interact with anti-apoptotic members ofthe family of bcl-2 proteins and use thereof |
| 01/23/2008 | CN101111515A Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 01/23/2008 | CN101111513A Glycopeptide antibiotic monomer derivative |
| 01/23/2008 | CN101111512A Methods of using macrocyclic modulators of the ghrelin receptor |
| 01/23/2008 | CN101111307A Process for producing coated fine particle |
| 01/23/2008 | CN101111260A Survivin peptide vaccine |
| 01/23/2008 | CN101111257A Methods of increasing cerebral blood flow |
| 01/23/2008 | CN101111256A Antimicrobial peptides and methods of use |
| 01/23/2008 | CN101111255A Methods for treating parkinson's disease |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 01/23/2008 | CN101111226A Medical product for inhalation containing glucagon-like peptide-1 (glp-1) |
| 01/23/2008 | CN101109012A Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof |
| 01/23/2008 | CN101109011A Novel modified corin molecules having substitute activation sequences and uses thereof |
| 01/23/2008 | CN101108895A Polyglycol ethanal derivant and combo of medicament and the same |
| 01/23/2008 | CN101108882A Fusion protein of HIV regulatory/accessory proteins |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108253A Biological separation dose treating femoral head ischemic necrosis |
| 01/23/2008 | CN101108246A Thymus gland pentapeptide oral intestine-dissolved formulated product and method of preparing the same and use thereof |
| 01/23/2008 | CN101108245A Formulated product used for human tumour combined treatment and use thereof |
| 01/23/2008 | CN101108175A Acid-alkaline buffering composition |
| 01/23/2008 | CN100363383C Micro-molecular polypeptides capable of combining with gold staphylococcus virulence factor regulatory protein and its pharmaceutical use |
| 01/23/2008 | CN100363355C Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds |
| 01/23/2008 | CN100363057C Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 01/23/2008 | CN100363055C Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 01/23/2008 | CN100363053C Intracellular isoform of the interleukin-1 receptor antagonist |
| 01/23/2008 | CN100363019C Cervus and cucumis polypeptide injection composition and preparing method |
| 01/23/2008 | CN100363014C Gugua polypeptide medicinal composition for injetion and preparing method therefor |
| 01/23/2008 | CN100362992C Nutritional composition for oral use |
| 01/22/2008 | USRE40023 Streptococcus thermophilus; Lactobacillus plantarum or Lactobacillus casei; optional bifidobacteria, Lactobacillus acidophilus, Lactobacillus delbrueckii sub-species bulgaricus and/or Streptococcus faecium); gastrointestinal disorders, hypercholestermia |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321028 Comprises leucine rich repeat domains; kits; drug screening; for treating apoptosis |
| 01/22/2008 | US7321024 Produced by a Paenibacillus polymyxa strain, used for reducing the levels of colonization by a target bacteria in animals, especially poultry. |
| 01/22/2008 | US7321023 SP16 protein |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320962 Hemoactive compositions and methods for their manufacture and use |
| 01/22/2008 | US7320961 UDP-glucuronosyltransferases (UGTs), UGT1A1 being a bilirubin-specific isozyme; inducing UGT1A1 isoform expression for treating unconjugated hyperbilirubinemia by administering ritonavir; side effect reduction of AIDS drugs such as indinavir, atazanavir, amphotericin B/cholesteryl sulfate complex |
| 01/22/2008 | US7320960 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/22/2008 | US7320959 Transgenic aniomal nmodels; screening; administering peptide |
| 01/22/2008 | US7320890 Soluble steroidal peptides for nucleic acid delivery |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320869 Antibodies to Chemokine Alpha-5 |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320793 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays |
| 01/22/2008 | US7320788 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating damaging effects of gluten |
| 01/22/2008 | US7320787 Genetic engineering; desroying infections; antitumor, anticancer agents |
| 01/22/2008 | US7320783 A method for treating a wound, comprising: providing an MMP prodomain peptide, and a subject having at least one wound; and administering said peptide to said subject under conditions such that the healing of said wound is promoted and |
| 01/22/2008 | US7320679 Therapeutic use of growth factor, and delivery device, especially for the treatment of intimal hyperplasia |
| 01/22/2008 | CA2436779C Human mitochondrial proteins and polynucleotides encoding the proteins |
| 01/22/2008 | CA2408251C Clearance of neoplastic cells from mixed cellular compositions using viruses |
| 01/22/2008 | CA2382535C Mixed micellar pharmaceutical delivery system and method of preparation |
| 01/22/2008 | CA2312431C New compounds |
| 01/22/2008 | CA2303807C Bioresorbable compositions for implantable prostheses |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2257133C Human dnase i hyperactive variants |
| 01/22/2008 | CA2158576C Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 01/17/2008 | WO2008008982A2 Modified annexin proteins and methods for their use in platelet storage and transfusion |
| 01/17/2008 | WO2008008981A1 Interleukin 21 and tyrosine kinase inhibitor combination therapy |
| 01/17/2008 | WO2008008873A2 Clc channel ligand |
| 01/17/2008 | WO2008008772A2 Methods for treating and limiting fibrotic disorders and keloids |
| 01/17/2008 | WO2008008561A2 Attenuation of reperfusion injury |
| 01/17/2008 | WO2008008549A2 Combination of an immunosuppressive agent and nonsteroidal anti -inflammatory drugs to treat neoplasia |
| 01/17/2008 | WO2008008523A1 COMPOUNDS THAT BIND α5β1 INTEGRIN AND METHODS OF USE |
| 01/17/2008 | WO2008008502A1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 01/17/2008 | WO2008008435A2 Methods, systems, and compositions for extracellular matrix production |
| 01/17/2008 | WO2008008363A1 Pharmaceutical compositions for sustained release delivery of peptides |
| 01/17/2008 | WO2008008358A2 Anti-cocaine compositions and treatment |
| 01/17/2008 | WO2008008357A1 Methods of treating obesity using satiety factors |
| 01/17/2008 | WO2008008348A2 Method and compositions for treating stroke with fever |
| 01/17/2008 | WO2008008311A1 Methods for administering tumor vaccines |
| 01/17/2008 | WO2008008264A2 Selective caspase inhibitors |
| 01/17/2008 | WO2008008113A1 Improved antibacterial antisense oligonucleotide and method |
| 01/17/2008 | WO2008008057A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/17/2008 | WO2008008047A1 Molecular probe for sphingolipids |
| 01/17/2008 | WO2008007997A1 External application anti-inflammatory agent |
| 01/17/2008 | WO2008007993A1 Use of a chorionic or luteinising hormone for preventing or treating age-dependent hypogonadism |
| 01/17/2008 | WO2008007933A1 Epidermal growth factor increasing insulin secretion and lowering blood glucose |
| 01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
| 01/17/2008 | WO2008007146A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | WO2008007131A2 Treatment for demyelinating disease |
| 01/17/2008 | WO2008007091A1 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 01/17/2008 | WO2008006922A1 Compounds for the treatment of diseases related to insulin resistance |
| 01/17/2008 | WO2008006893A1 Muteins of hngf, therapeutic uses and pharmaceutical compositions |
| 01/17/2008 | WO2008006544A2 Use of gelatin and a cross-linking agent for producing a cross-linking therapeutic composition |
| 01/17/2008 | WO2008006467A1 Antimicrobial peptide derived from galanin message associated peptide (gmap) |
| 01/17/2008 | WO2008006458A2 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |